Cerebrospinal fluid biomarkers at presentation associate with etiologic diagnosis and treatment responsiveness in patients with rapidly progressive dementia.

MLA

Kuchenbecker, Lindsey A., et al. “Cerebrospinal Fluid Biomarkers at Presentation Associate with Etiologic Diagnosis and Treatment Responsiveness in Patients with Rapidly Progressive Dementia.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, Dec. 2023, pp. 1–2. EBSCOhost, https://doi.org/10.1002/alz.073864.

APA

Kuchenbecker, L. A., Tipton, P. W., Martens, Y. A., Brier, M. R., Satyadev, N., Dunham, S. R., Lazar, E., Dacquel, M. V., Bu, G., Geschwind, M. D., Morris, J. C., Schindler, S. E., Fagan, A. M., Graff, R. N. R., & Day, G. S. (2023). Cerebrospinal fluid biomarkers at presentation associate with etiologic diagnosis and treatment responsiveness in patients with rapidly progressive dementia. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19, 1–2. https://doi.org/10.1002/alz.073864

Chicago

Kuchenbecker, Lindsey A, Philip W Tipton, Yuka A Martens, Matthew R Brier, Nihal Satyadev, S Richard Dunham, Evelyn Lazar, et al. 2023. “Cerebrospinal Fluid Biomarkers at Presentation Associate with Etiologic Diagnosis and Treatment Responsiveness in Patients with Rapidly Progressive Dementia.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (December): 1–2. doi:10.1002/alz.073864.